Publications
- Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "watch and wait" strategy after complete resection2013 | Second Faculty of Medicine
- Influence of amiphostine on reduction of acute toxicity in anticancer megachemotherapy in children2002 | Second Faculty of Medicine
- Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients2000 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Treatment of Hodgkin's Disease in Children with Vamp (Vinblastine, Adriamycin, Methotrexate, Prednisone) and Vepa (Vinblastine, Etoposide, Prednisone, Adriamycin)1999 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Treatment of children and adolescents with non-Hodgkin's lymphoma. (Results based on the NHL Berlin-Frankfurt-Münster 90 protocols)1998 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Molecular Screening in ALK-Positive Anaplastic Large Cell Lymphoma: ALK Analysis, NGS Fusion Gene Detection, and T-cell Receptor Immunoprofiling2024 | Second Faculty of Medicine, Third Faculty of Medicine
- Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group2024 | Second Faculty of Medicine, Third Faculty of Medicine
- Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?2024 | Second Faculty of Medicine
- Ibrutinib plus RICE/RVICI for R/R mature B-NHL in children/young adults: SPARKLE trial2023 | Second Faculty of Medicine
- Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma2023 | Second Faculty of Medicine
Loading network view...